In PSM analysis almost all transfusion patients were on medication for hypertension, and we observed no difference in the usage of betablockers, ACE-inhibitors/angiotensin receptor blockers or calcium-channel blockers between transfusion groups. This evidence concerns the gene ACE and hypertensive disorder.